These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 1943724

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis.
    Attman PO, Samuelsson OG, Moberly J, Johansson AC, Ljungman S, Weiss LG, Knight-Gibson C, Alaupovic P.
    Kidney Int; 1999 Apr; 55(4):1536-42. PubMed ID: 10201020
    [Abstract] [Full Text] [Related]

  • 3. Impaired metabolism of high density lipoprotein in uremic patients.
    Shoji T, Nishizawa Y, Nishitani H, Yamakawa M, Morii H.
    Kidney Int; 1992 Jun; 41(6):1653-61. PubMed ID: 1501422
    [Abstract] [Full Text] [Related]

  • 4. Lipoprotein(a) and apolipoprotein(a) phenotypes in patients with end-stage renal disease.
    Kim SB, Yang WS, Kang ES, Min WK, Park JS.
    Perit Dial Int; 1997 Jun; 17(3):236-42. PubMed ID: 9237283
    [Abstract] [Full Text] [Related]

  • 5. The uremic dyslipidemia: a cross-sectional and longitudinal study.
    Avram MM, Goldwasser P, Burrell DE, Antignani A, Fein PA, Mittman N.
    Am J Kidney Dis; 1992 Oct; 20(4):324-35. PubMed ID: 1415199
    [Abstract] [Full Text] [Related]

  • 6. Gemfibrozil improves abnormalities of lipid metabolism in patients on continuous ambulatory peritoneal dialysis: the role of postheparin lipases in the metabolism of high-density lipoprotein subfractions.
    Chan MK.
    Metabolism; 1989 Oct; 38(10):939-45. PubMed ID: 2507877
    [Abstract] [Full Text] [Related]

  • 7. Reduction of intermediate density lipoprotein by pravastatin in hemo- and peritoneal dialysis patients.
    Nishizawa Y, Shoji T, Emoto M, Kawasaki K, Konishi T, Tabata T, Inoue T, Morii H.
    Clin Nephrol; 1995 Apr; 43(4):268-77. PubMed ID: 7606882
    [Abstract] [Full Text] [Related]

  • 8. Postheparin plasma lipoprotein and hepatic lipase are determinants of hypo- and hyperalphalipoproteinemia.
    Kuusi T, Ehnholm C, Viikari J, Härkönen R, Vartiainen E, Puska P, Taskinen MR.
    J Lipid Res; 1989 Aug; 30(8):1117-26. PubMed ID: 2504859
    [Abstract] [Full Text] [Related]

  • 9. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins.
    Kanbay M, Delibasi T, Kaya A, Aydogan T, Koca C, Akcay A, Duranay M, Yigitoglu R.
    Ren Fail; 2006 Aug; 28(7):567-71. PubMed ID: 17050239
    [Abstract] [Full Text] [Related]

  • 10. Effect of lipoprotein lipase and hepatic triglyceride lipase activity on the distribution of apolipoprotein E among the plasma lipoproteins.
    Gibson JC, Brown WV.
    Atherosclerosis; 1988 Sep; 73(1):45-55. PubMed ID: 3178931
    [Abstract] [Full Text] [Related]

  • 11. Hyperapobetalipoproteinemia: the major dyslipoproteinemia in patients with chronic renal failure treated with chronic ambulatory peritoneal dialysis.
    Sniderman A, Cianflone K, Kwiterovich PO, Hutchinson T, Barre P, Prichard S.
    Atherosclerosis; 1987 Jun; 65(3):257-64. PubMed ID: 3619989
    [Abstract] [Full Text] [Related]

  • 12. Lipid levels in monocytes of patients with moderate hyperlipoproteinemia.
    Querfeld U, Wendtland J, von Hodenberg E, Mehls O.
    Atherosclerosis; 1992 Jun; 94(2-3):129-34. PubMed ID: 1632866
    [Abstract] [Full Text] [Related]

  • 13. Decreased activities of lipoprotein lipase and hepatic triglyceride lipase in patients with gout.
    Tsutsumi Z, Yamamoto T, Moriwaki Y, Takahashi S, Hada T.
    Metabolism; 2001 Aug; 50(8):952-4. PubMed ID: 11474484
    [Abstract] [Full Text] [Related]

  • 14. Concentration of Lp(a) and other apolipoproteins in predialysis, hemodialysis, chronic ambulatory peritoneal dialysis and post-transplant patients.
    Kimak E, Solski J, Janicka L, Ksaziek A, Janicki K.
    Clin Chem Lab Med; 2000 May; 38(5):421-5. PubMed ID: 10952225
    [Abstract] [Full Text] [Related]

  • 15. Lipids, lipoproteins and apolipoproteins abnormalities in patients undergoing dialysis.
    Yang X, Wang H, Zhu Z, Deng A.
    J Tongji Med Univ; 1997 May; 17(2):126-8. PubMed ID: 9639806
    [Abstract] [Full Text] [Related]

  • 16. Effect of heparin-induced lipolysis on the distribution of apolipoprotein e among lipoprotein subclasses. Studies with patients deficient in hepatic triglyceride lipase and lipoprotein lipase.
    Rubinstein A, Gibson JC, Paterniti JR, Kakis G, Little A, Ginsberg HN, Brown WV.
    J Clin Invest; 1985 Feb; 75(2):710-21. PubMed ID: 3973025
    [Abstract] [Full Text] [Related]

  • 17. Two weeks of daily injections and continuous infusion of recombinant human growth hormone (GH) in GH-deficient adults. II. Effects on serum lipoproteins and lipoprotein and hepatic lipase activity.
    Oscarsson J, Ottosson M, Johansson JO, Wiklund O, Mårin P, Björntorp P, Bengtsson BA.
    Metabolism; 1996 Mar; 45(3):370-7. PubMed ID: 8606646
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Erythropoietin supplement increases plasma lipoprotein lipase and hepatic triglyceride lipase levels in hemodialysis patients.
    Goto T, Saika H, Takahashi T, Maeda A, Mune M, Yukawa S.
    Kidney Int Suppl; 1999 Jul; 71():S213-5. PubMed ID: 10412779
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.